Abstract
Syngeneic SL mice inoculated with murine myeloid leukemia cells (M1) all died of leukemia within 30 days. Treatment three times a week with 12.5-50 pmol per mouse of either 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], the active form of vitamin D3, or its synthetic analog, 1 alpha-hydroxyvitamin D3 [1 alpha(OH)D3], considerably prolonged the survival time of mice inoculated with M1 cells. 1 alpha(OH)D3 was more effective than 1 alpha,25(OH)2D3 in increasing the survival time of the mice. 1 alpha(OH)D3 also increased the survival time of nude mice inoculated with M1 cells. The 1 alpha(OH)[3H]D3 administered intraperitoneally to tumor-bearing mice was converted very rapidly to 1 alpha,25(OH)2-[3H]D3. The chronic administration of 25 pmol of 1 alpha(OH)D3 to tumor-bearing mice for 30 days caused no appreciable hypercalcemia. These results indicate clearly that 1 alpha,25(OH)2D3 is effective not only in inducing differentiation of M1 cells in vitro, as previously reported [Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S. & Suda, T. (1981) Proc. Natl. Acad. Sci. USA 78, 4990-4994], but also in prolonging the survival time of mice inoculated with M1 cells.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
- Benade L., Howard T., Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology. 1969;23(1):33–43. doi: 10.1159/000224465. [DOI] [PubMed] [Google Scholar]
- Bishun N., Basu T. K., Metcalfe S., Williams D. C. The effect of ascorbic acid (vitamin C) on two tumor cell lines in culture. Oncology. 1978;35(4):160–162. doi: 10.1159/000225276. [DOI] [PubMed] [Google Scholar]
- Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A. 1980 May;77(5):2936–2940. doi: 10.1073/pnas.77.5.2936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brumbaugh P. F., Haussler M. R. 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. J Biol Chem. 1974 Feb 25;249(4):1258–1262. [PubMed] [Google Scholar]
- Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
- Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978 May;75(5):2458–2462. doi: 10.1073/pnas.75.5.2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colston K., Colston M. J., Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981 Mar;108(3):1083–1086. doi: 10.1210/endo-108-3-1083. [DOI] [PubMed] [Google Scholar]
- Connerty H. V., Briggs A. R. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol. 1966 Mar;45(3):290–296. doi: 10.1093/ajcp/45.3.290. [DOI] [PubMed] [Google Scholar]
- DeLuca H. F., Schnoes H. K. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem. 1976;45:631–666. doi: 10.1146/annurev.bi.45.070176.003215. [DOI] [PubMed] [Google Scholar]
- Eisman J. A., Martin T. J., MacIntyre I., Frampton R. J., Moseley J. M., Whitehead R. 1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells). Biochem Biophys Res Commun. 1980 Mar 13;93(1):9–15. doi: 10.1016/s0006-291x(80)80238-5. [DOI] [PubMed] [Google Scholar]
- Freake H. C., Marcocci C., Iwasaki J., MacIntyre I. 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem Biophys Res Commun. 1981 Aug 31;101(4):1131–1138. doi: 10.1016/0006-291x(81)91565-5. [DOI] [PubMed] [Google Scholar]
- Fukushima M., Suzuki Y., Toira Y., Matsunaga I., Ochi K., Nagano H. Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver. Biochem Biophys Res Commun. 1975 Sep 16;66(2):632–638. doi: 10.1016/0006-291x(75)90556-2. [DOI] [PubMed] [Google Scholar]
- Holick M. F., Tavela T. E., Holick S. A., Schnoes H. K., DeLuca F., Gallagher B. M. Synthesis of 1alpha-hydroxy [6-3H]vitamin D3 and its metabolism to 1alpha, 25-dihydroxy [6-3H]vitamin D3 in the rat. J Biol Chem. 1976 Feb 25;251(4):1020–1024. [PubMed] [Google Scholar]
- Honma Y., Kasukabe T., Hozumi M. Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells. J Natl Cancer Inst. 1978 Sep;61(3):837–841. [PubMed] [Google Scholar]
- Honma Y., Kasukabe T., Okabe J., Hozumi M. Glucocorticoid binding and mechanism of resistance in some clones of mouse myeloid leukemic cells resistant to induction of differentiation by dexamethasone. J Cell Physiol. 1977 Nov;93(2):227–235. doi: 10.1002/jcp.1040930208. [DOI] [PubMed] [Google Scholar]
- Honma Y., Kasukabe T., Okabe J., Hozumi M. Glucorticoid-induced differentiation of cultured mouse myeloid leukemia cells. Gan. 1977 Apr;68(2):241–246. [PubMed] [Google Scholar]
- Honma Y., Kasukabe T., Okabe J., Hozumi M. Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation. Cancer Res. 1979 Aug;39(8):3167–3171. [PubMed] [Google Scholar]
- Honma Y., Takenaga K., Kasukabe T., Hozumi M. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun. 1980 Jul 31;95(2):507–512. doi: 10.1016/0006-291x(80)90813-x. [DOI] [PubMed] [Google Scholar]
- Huberman E., Callaham M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1293–1297. doi: 10.1073/pnas.76.3.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969 Dec;74(3):223–234. doi: 10.1002/jcp.1040740303. [DOI] [PubMed] [Google Scholar]
- Ikekawa N., Koizumi N. Separation of vitamin D metabolites and their analogues by high-pressure liquid chromatography. J Chromatogr. 1976 Apr 28;119:227–232. doi: 10.1016/s0021-9673(00)86786-2. [DOI] [PubMed] [Google Scholar]
- Kanis J. A., Russell R. G. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Br Med J. 1977 Jan 8;1(6053):78–81. doi: 10.1136/bmj.1.6053.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lotem J., Sachs L. Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int J Cancer. 1975 May 15;15(5):731–740. doi: 10.1002/ijc.2910150504. [DOI] [PubMed] [Google Scholar]
- Lotem J., Sachs L. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5158–5162. doi: 10.1073/pnas.76.10.5158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manolagas S. C., Deftos L. J. Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3. Biochem Biophys Res Commun. 1980 Jul 31;95(2):596–602. doi: 10.1016/0006-291x(80)90826-8. [DOI] [PubMed] [Google Scholar]
- Mason J. B., Hay R. W., Leresche J., Peel S., Darley S. The story of vitamin D: from vitamin to hormone. Lancet. 1974 Mar 2;1(7853):325–329. [PubMed] [Google Scholar]
- Miyaura C., Abe E., Kuribayashi T., Tanaka H., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1981 Oct 15;102(3):937–943. doi: 10.1016/0006-291x(81)91628-4. [DOI] [PubMed] [Google Scholar]
- PEEL J. L., LOUGHMAN B. C. Some observations on the role of copper ions in the reduction of phosphomolybdate by ascorbic acid and their application in the determination of inorganic orthophosphate. Biochem J. 1957 Apr;65(4):709–716. doi: 10.1042/bj0650709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature. 1978 Aug 10;274(5671):535–539. doi: 10.1038/274535a0. [DOI] [PubMed] [Google Scholar]
- Tanaka H., Abe E., Miyaura C., Kuribayashi T., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982 Jun 15;204(3):713–719. doi: 10.1042/bj2040713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tohira Y., Ochi K., Matsunaga I., Fukushima M., Takanshi S. Synthesis of 1 alpha-[2(-3)H]Hydroxyvitamin D. Anal Biochem. 1977 Feb;77(2):495–502. doi: 10.1016/0003-2697(77)90263-9. [DOI] [PubMed] [Google Scholar]
- Weiss B., Sachs L. Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1374–1378. doi: 10.1073/pnas.75.3.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
